Patient underwent cataract surgery
Conditions
Interventions
Topical instillation: levofloxacin 1.5% ophthalmic solution 4 times per day Administration period after cataract surgery: One week, 50 patients, 50eyes.
Topical instillation: levofloxacin 1.5% opht
Sponsors
Miyata Eye Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients with bacteria examination within three months of cataract surgery. 2) Patients to obtain the written consent
Exclusion criteria
Exclusion criteria: 1) Patients with a history of antibiotics prescription within three months prior to the study. 2) Patients with a history of hypersensitivity or severe adverse effects by fluoroquinolones. 3) Glaucoma patients treated with ophthalmic solutions 4) Patients under steroid ophthalmic solutions 5) Patients under immunosuppressive therapy 6) Patients suspecting to be any infectious ocular diseases. 7) Patients whom investigators considered not to be are eligible.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Antibiotic susceptibility of isolated bacteria (pre operation,end of instillation, post 1 3 6 9 12 months) | — |
Secondary
| Measure | Time frame |
|---|---|
| Prevalenced bacterialin species in the conjunctiva flora. Change of antibiotic resistant. | — |
Countries
Japan
Contacts
Public ContactRyohei NEJIMA
Miyata Eye Hospital Miyata Eye Hospital
Outcome results
None listed